The institute Fried is founding at Reichman University will explore more than direct brain stimulation and hybrid brains. "We ...
Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
In simple terms, PEMF is a noninvasive treatment that uses gentle electromagnetic pulses to stimulate your body at a cellular ...
Morning Overview on MSN
New antibody stops one of the deadliest breast cancers
One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving ...
The billionaire-backed “Doping Games” is luring Olympian-caliber athletes with cash, drugs, and science. Are these athletes ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing*First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and ...
Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
By increasing neuroplasticity, psychedelics may both enhance creativity and be useful for treating a variety of psychiatric ...
Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback